AMN Healthcare Services, Inc. Stock News

AMN vs. PGNY: Which Stock Is the Better Value Option?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

AMN Healthcare Services, Inc. (NYSE:AMN ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Randle Reece – Senior Director-Investor Relations Susan Salka – Chief Exec

AMN Healthcare's (AMN) robust Q2 results demonstrate its segmental strength.

AMN Healthcare has been outperforming the S&P 500 over the past six months. The post AMN Healthcare Nears Buy Point Ahead Of Earnings Report appeared first on Investor's Business Daily.

The decline in U.S. GDP during the first quarter and 26% decline in the S&P 500 Index so far this year fuel the risk of a recession. MCK, PDCO & AMN have the potential to help investors ward off volat

AMN Healthcare (AMN) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it throug

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our accomplishments from last week.

Investors target stocks that have been on a bullish run lately. Stocks like AMN, OTTR, ECPG and CBOE that are seeing price strength have a high chance of carrying the momentum forward.

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Sanderson (SAFM), Otter Tail (OTTR), J&J Snack Foods (JJSF) and AMN Healthcare (AMN) are well poised to gain.

U.S. market indexes kicked off the week lower as investors prepare for the start of second-quarter earnings season.

DALLAS--(BUSINESS WIRE)--AMN Healthcare Services, Inc. (NYSE: AMN) has scheduled a conference call to discuss its second quarter 2022 financial results and third quarter 2022 outlook on Thursday, Augu

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. United Therapeutics (UTHR), Sanderson (SAFM) and AMN Healthcare (AMN) are well poised to gain.

AMN Healthcare (AMN) continues to benefit from its broad range of services.

AMR, SBOW, AMN, BVH, and EGLE have been added to the Zacks Rank #1 (Strong Buy) List on June 24, 2022.